Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP567809.RAhX1noCPaf7HDLVZo3qqtnoT2-ThN0j4eB33kiWJXw2M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP567809.RAhX1noCPaf7HDLVZo3qqtnoT2-ThN0j4eB33kiWJXw2M130_assertion type Assertion NP567809.RAhX1noCPaf7HDLVZo3qqtnoT2-ThN0j4eB33kiWJXw2M130_head.
- NP567809.RAhX1noCPaf7HDLVZo3qqtnoT2-ThN0j4eB33kiWJXw2M130_assertion description "[KLK2/3-expressing CTCs are common in men with CRPC and bone metastases but are rare in patients with metastases diagnosed only in soft tissues and patients with localized cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP567809.RAhX1noCPaf7HDLVZo3qqtnoT2-ThN0j4eB33kiWJXw2M130_provenance.
- NP567809.RAhX1noCPaf7HDLVZo3qqtnoT2-ThN0j4eB33kiWJXw2M130_assertion evidence source_evidence_literature NP567809.RAhX1noCPaf7HDLVZo3qqtnoT2-ThN0j4eB33kiWJXw2M130_provenance.
- NP567809.RAhX1noCPaf7HDLVZo3qqtnoT2-ThN0j4eB33kiWJXw2M130_assertion SIO_000772 19233911 NP567809.RAhX1noCPaf7HDLVZo3qqtnoT2-ThN0j4eB33kiWJXw2M130_provenance.
- NP567809.RAhX1noCPaf7HDLVZo3qqtnoT2-ThN0j4eB33kiWJXw2M130_assertion wasDerivedFrom befree-20140225 NP567809.RAhX1noCPaf7HDLVZo3qqtnoT2-ThN0j4eB33kiWJXw2M130_provenance.
- NP567809.RAhX1noCPaf7HDLVZo3qqtnoT2-ThN0j4eB33kiWJXw2M130_assertion wasGeneratedBy ECO_0000203 NP567809.RAhX1noCPaf7HDLVZo3qqtnoT2-ThN0j4eB33kiWJXw2M130_provenance.